Sara Manglaviti

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Radical Prostatectomy

Epidermal Growth Factor Receptor

Top Venues

Journal of personalized medicine

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Leporati, Daniela Miliziano, Teresa Beninato, Laura Mazzeo, Sara Manglaviti, Marta Brambilla, Mario Alberto Occhipinti, Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs. Tumori (2024)
Mario Alberto Occhipinti, Marta Brambilla, Giulia Galli, Sara Manglaviti, Maristella Giammaruco, Arsela Prelaj, Roberto Ferrara, Alessandro De Toma, Claudia Proto, Teresa Beninato, Emma Zattarin, Giuseppe Lo Russo, Alain Jonathan Gelibter, Maurizio Simmaco, Robert Preissner, Marina Chiara Garassino, Filippo De Braud, Paolo Marchetti
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors. Journal of personalized medicine 11 (5) (2021)
Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, Sara Manglaviti, Marina Chiara Garassino, Mario Alberto Occhipinti
Is hyperprogressive disease a specific phenomenom of immunotherapy? Exploration of targeted anti-tumor therapy 1 (6) (2020)
Francesca Corti, Marta Brambilla, Sara Manglaviti, Laura Di Vico, Maria Neve Pisanu, Claudia Facchinetti, Katia Fiorella Dotti, Rodolfo Lanocita, Alfonso Marchianò, Filippo de Braud, Laura Anna Maria Ferrari
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis. Tumori 107 (1) (2020)